Digest Network Come funziona
Network
/
Società
Pr
Non verificato

Pretzel Therapeutics

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

4 comunicati stampa

Guarda tutti i comunicati
04/11/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Industria
Pretzel Therapeutics Presents Preclinical Data Supporting POLRMT as a Novel Target for the Treatment of Metabolic Disease at ObesityWeek 2025
Fonte
Pretzel Therapeutics
Emittente
Business Wire
1.00
0
03/09/2025
Pretzel Therapeutics Strengthens Leadership with Appointment of Ashish Dugar, Ph.D., MBA as Chief Development Officer
Fonte
Pretzel Therapeutics
Emittente
Business Wire
1.00
0
09/04/2025
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Pretzel Therapeutics Announces Publication in Nature Unveiling Discovery of Novel Small Molecule Activators for the Treatment of POLG Disorders and Other Conditions Related to mtDNA Depletion
Fonte
Pretzel Therapeutics
Emittente
Business Wire
1.00
0
03/04/2025
Industria
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Sanità
Pretzel Therapeutics Initiates Phase 1 Clinical Study Evaluating PX578, Lead Therapeutic in its Bioenergetics Restoration Franchise
Fonte
Pretzel Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0